BREASTANBUL 2026

Register

The Conference

Scientific Programme

Thursday, 8 October 2026

  1. Hall A Live surgery

    Session: Live Surgery

    Oncoplastic and Reconstructive Breast Surgery

    1. Room 1. Case: Endoscopic nipple-areola complex sparing total mastectomy + immediate reconstruction + ICG asissted Sentinel Lymph Node Biopsy (SLNB) Cihan Uras, Halil Kara, Buse Capkinoglu
    2. Room 2. Case: Therapeutic mammoplasty Andreas Karakatsanis, Onur Dülgeroğlu
  2. Hall C

    Session I

    Beyond Borders: The Power of Patient Advocacy

    1. Opening Remarks Violet Aroyo, Marzia Zambon
    2. Beyond borders: The power of patient advocacy Mary Jimenez
    3. Conversation & Panel discussion Mary Jimenez, Violet Aroyo, Marzia Zambon
  3. Hall D Course

    Course: Breast Radiology

    Changing Role and Trends in Radiological Diagnosis and Management

    1. SESSION I New Screening Strategies Gül Esen, Erkin Arıbal
    2. Real-world screening scenarios: Does one size fit all? Aysenur Oktay
    3. Role of AI in breast cancer detection and risk assessment Nico Karssemejer
    4. Supplemental screening with DBT and US! Do we still need them? Alexandra Athanasiou
    5. Screening with contrast-enhanced methods: Why and when? Thiemo Van Nijnatten
    6. Panel Discussion: On the road to personalized screening Gül Esen, Erkin Arıbal · Nico Karssemejer, Alexandra Athanasiou, Thiemo Van Nijnatten, Aysenur Oktay
    7. Coffee Break
    8. SESSION II Radiological Management of Breast Cancer Aysenur Oktay, Sebnem Orguc
    9. Radiologist’s role as a decision maker in treatment planning Pascal Baltzer
    10. Shifting paradigms of axilla: Where does radiology stand? Valeria Romeo
    11. Role of radiology in evaluation of response to neoadjuvant therapy Onur Bugdayci
    12. Radiologic follow-up of patients after breast cancer surgery Serap Gultekin
    13. Q&A / Discussion
    14. SATELLITE SYMPOSIUM PRONE Biopsy: Indications, Techniques and Clinical Practice Emel Esmerer
    15. Lunch
    16. SESSION III Contrast Enhanced Mammography Mehmet Halit Yilmaz, Nur Soylu Boy
    17. Implementing into clinical practice Norran Hussein
    18. Challenging cases and pitfalls Sebnem Orguc
    19. CEM vs MRI-guided Biopsy Erkin Arıbal
    20. Q&A / Discussion
    21. Panel Discussion: CEM vs MRI in clinical practice Mehmet Halit Yilmaz, Nur Soylu Boy · Norran Hussein, Sebnem Orguc, Erkin Arıbal
    22. Coffee Break
  4. Hall C

    Session II

    Globalization and the Future of Breast Cancer

    1. The future of breast nursing: A message from tomorrow Derya Subaşı Sezgin
    2. From awareness to influence: The evolving role of patient advocacy Violeta Pirana
    3. New horizons in digital health: AI-supported decision systems Mahmut Dagci
    4. Q&A / Discussion
  5. Hall B Workshop

    Workshop: Medical Oncology

    Current Management of Breast Cancer with Contemporary Systemic Treatment

    1. Session I: Early Breast Cancer Yeşim Eralp
    2. Introduction
    3. Case Discussions (15 min × 8 tables)
    4. Panel Discussion Yeşim Eralp
    5. Lunch
    6. SATELLITE SYMPOSIUM Who Truly Needs Chemotherapy? New Evidence from OPTIMA in ER+/HER2− Early Breast Cancer Erhan Gokmen
    7. Session II: Metastatic Breast Cancer Özlem Sönmez
    8. Case Discussions (15 min × 8 tables)
    9. Panel Discussion Özlem Sönmez
  6. Hall C

    Coffee Break

  7. Hall C

    Session III

    Understanding the Patient Journey: From Diagnosis to Adaptation

    1. Emotional responses to diagnosis: What nurses need to recognize Selda Rizalar
    2. Communication and trust-building in the first encounter Gizem Sahin Bayindir
    3. Helping patients navigate uncertainty after diagnosis: Information, clarity, and support Grazyna Suchodolska
    4. Guiding patients toward adaptation: Support strategies Sevil Guler
    5. Q&A / Discussion
  8. Hall A Satellite symposium

    Satellite Symposium

    Beyond Hemostasis: A Proactive Approach to Breast Cancer Surgery · A Smarter Approach to Breast Cancer Surgery: Reducing Seroma and Improving Recovery

  9. Hall A Keynote

    Keynote Lecture

    De-escalation of axillary management: Insights from SINODAR-ONE and NEONOD studies

  10. Hall A

    Lunch

  11. Hall A

    iBreastBook Session

    Mammoplasties & Volume Displacement Techniques

    1. Marking & planning Yazan Masannat
    2. Excision volumes and volumetric assessments Andreas Karakatsanis
    3. Not all mammoplasties are the same Michalis Kontos
    4. The wise pattern Sarah Downey
    5. When things go wrong Ashutosh Kothari
    6. Yazan Masannat · Case discussion, Hasan Karanlık, Leena Chagla, Michalis Kontos, Andreas Karakatsanis, Sarah Downey, Ashutosh Kothari
  12. Hall C

    Session IV

    Breast Cancer & Strength: Nursing Support Through Treatment and Its Impacts

    1. Talking to children about cancer Tugba Pehlivan
    2. Coping with treatment-related fertility loss and the grief of motherhood Merve Tuncer
    3. Partner support and nursing roles during treatment Arzu Tuna
    4. Supporting patients’ social relationships and emotional well-being Seda Er
    5. A patient’s journey through breast cancer: What we need to hear Bengi Kepkep
    6. Q&A / Discussion
  13. Hall A

    Coffee Break

  14. Hall A

    Association of Breast Surgeons of India (ABSI) Session

    Chest Wall Perforator Flap (PF) Reconstruction

    Chairs
    DG Vijay
    1. Evolution and scope of perforator flaps in India Sanjit Agrawal
    2. AICAP and MICAP flaps DG Vijay
    3. LTAP & TDAP flaps Sanjit Agrawal
    4. LICAP Ashutosh Mishra
    5. Transposition flaps Shalaka Joshi
    6. Panel Discussion: Optimal selection of perforator flaps – case based scenarios DG Vijay · Sanjit Agrawal, Ashutosh Mishra, Shalaka Joshi, Dushyant Jaıswal
    7. Q&A / Discussion
  15. Hall C

    Session V

    The Role of Genetics in Modern Breast Cancer Care

    1. Breast cancer genetics: Basics, testing and decision-making Ahmet Yesilyurt
    2. The nursing role in genetic counseling: Education, coordination, and support Sally Kum
    3. Q&A / Discussion
    4. Sally Kum · implementation, outcomes, Ahmet Yesilyurt, Elif Şenocak Taşçı, Yasemin Atagun, Fiorita Poulakaki, Dan Hershko
  16. Hall D

    Session IV

    Interventions

    1. Role of cryoablation in breast cancer treatment Inci Kizildag
    2. Vacuum excision as a therapeutic procedure Nisha Sharma
    3. Nonsurgical locoregional treatment modalities: What are the oncological prospects for omission of surgery Bahadır M. Güllüoğlu
    4. Q&A / Discussion
    5. Closure
  17. Hall A Ceremony

    Opening Ceremony

    1. Opening remarks Cihan Uras
    2. OPENING CONFERENCE Opening Speech: Recent advances and future prospects in early breast cancer Nuran Beşe, Nil Mandel · William J. Gradishar

Friday, 9 October 2026

  1. Hall A

    GReTA Session

    Critical-Thinking: Lessons Taken From Mistakes in Breast Surgery

  2. Hall B

    Early Morning Radiology Session

    Commanding the invisible – Radiologists as true co-pilots of surgery: Breast imaging cases from the starfleet

  3. Hall C

    Early Morning Breast Care Nursing Session

    Scientific Writing: From Idea to Publication

  4. Hall A

    Plastic and Reconstructive Surgery Session I

    Autologous Tissue Breast Reconstruction

    1. The evolution of autologous breast reconstruction Christoph Andree
    2. The autologous flaps alternative to DIEP flap Eric Santamaria
    3. Delayed autologous breast reconstruction. Current controversies and unresolved challenges Aziz Zikiryakhodzhaev
    4. Tips and tricks for the aesthetic autologous flap reconstruction Jaume Masia
    5. My second best choice after failed free flap for breast reconstruction? Christoph Andree
    6. Complications and management in breast reconstruction Sühan Ayhan
    7. Q&A / Discussion
  5. Hall B

    Medical Oncology Session I

    Changing Landscape of Systemic Treatment in Metastatic Disease: Emerging Treatment Options and Sequencing

    1. HR+ disease Hope Rugo
    2. HER2+ disease Başak Oyan Uluç
    3. Triple-negative breast cancer Sana Al Sukhun
    4. Advances in management of CNS metastases Rupert Bartsch
    5. Q&A / Discussion
  6. Hall C

    Session VI

    Integrative Oncology in Breast Cancer Survivorship: Evidence, Safety, and Multidisciplinary Practice

    1. Why integrative oncology matters in survivorship: Evidence & real-world Sevilay Altıntaş
    2. Lifestyle medicine interventions in breast cancer management Taner Kivilcim
    3. Nutrition & supplements: What helps, what harms + safety framework Dilsat Bas
    4. The nursing role in integrative oncology: Assessment, patient education, and safe practice Grazyna Suchodolska
    5. Q&A / Discussion
  7. Hall D

    Pathology Session I

    B3 Lesions According to Guidelines

    1. Pathology of intraductal epithelial proliferation (ADH, lobular neoplasia, FEA) Sarah Pinder
    2. Pathology of radial scar, papilloma and differential from other papillary lesions Cecily Quinn
    3. Miscellaneous B3 lesions Abeer Shaaban
    4. Tricky B3 lesions: Difficult lesions and approach to diagnosis Cecily Quinn
    5. Management of B3 lesions: International guidelines Abeer Shaaban
  8. Hall E

    Surgical Innovation Special Session

    India Innovation Session · (Closed Meeting Only by Invitation)

    1. Introduction Ashutosh Mishra
    2. Innovative Margin Assessment Theo Ruers
    3. ICG Innovation in India Sanjit Agrawal
    4. Innovative use of US-AI in Breast Surgery Behdad D. Bozorg
    5. Indigenous ADM innovation from India Sanjay Yadav
    6. Innovative Fat Grafting: A new way for regenerative medicine Andrzej Piatkowski
    7. High-quality affordable tactile simulation innovation Ozge Akbulut
  9. Hall A Satellite symposium

    Satellite Symposium

    Galaflex (P4HB Mesh) Use in Breast Aesthetics. Revision & Reconstruction

  10. Hall B Satellite symposium

    Satellite Symposium

    Pembrolizumab in Triple Negative Breast Cancer

  11. Hall D

    Q&a / Discussion

  12. Hall E

    Q&a / Discussion

  13. Hall E

    Closure

  14. All halls

    Coffee Break

  15. Hall A

    Plastic and Reconstructive Surgery Session II

    Implant Based Breast Reconstruction

    1. Revisiting the retropectoral approach: Optimizing aesthetic outcomes Akin Yucel
    2. Biosynthetic versus biologic mesh; or nothing else in implant-based breast reconstruction Jaume Masia
    3. Cultural aspects in breast reconstruction Sinikka Suominen
    4. Skin-reducing mastectomy in large and ptotic breasts: A safe and predictable reconstructive strategy Burcu Celet Ozden
    5. Hybrid breast reconstruction Eric Santamaria
    6. Individualization of the choice of breast reconstruction method: A comparative analysis of the use of autologous flaps and implants Maria Ermoshenkova
    7. Where do implants fit in my breast reconstruction algorithm? Gemma Pons
    8. Residual breast tissue after prophylactic mastectomy and implant breast reconstruction Moustapha Hamdi
    9. Q&A / Discussion
  16. Hall B

    Radiology Session

    Essentials of Imaging for Better Patient Outcomes

    1. What to do for ADH, ALH and LCIS after core bx? Pascal Baltzer
    2. Trends in risk-based screening Thiemo Van Nijnatten
    3. Can we predict axillary status in breast cancer? Valeria Romeo
    4. Future of AI in breast imaging Nico Karssemejer
    5. Current & potential roles of breast MRI in patients receiving neoadjuvant systemic treatment Alexandra Athanasiou
    6. Image-guided ablation: A new frontier for breast cancer management Nisha Sharma
    7. Q&A / Discussion
  17. Hall C

    Session VII

    Breast Cancer Care Today: Costs, Challenges, and Value

    1. Stage-based breast cancer treatments: Balancing rising drug and test costs with value Umit Dereli
    2. Financial toxicity: The invisible burden Sally Kum
    3. Institutional perspectives in breast cancer management: Workforce, workload, and sustainability Cagri Satir
    4. Value in breast cancer care: Survey findings from Turkiye Mehmet Ali Nahit Sendur
    5. The sustainability of breast cancer treatment in a changing global economy Farid Bidgoli
    6. Q&A / Discussion
  18. Hall D

    Pathology Session II

    Applications of Digital Pathology & Artificial Intelligence (AI)

    1. AI algorithms in HER2 assessment Andrew Dodson
    2. AI algorithms for assessment of lymph nodes Sarah Pinder
    3. Implementing digital pathology: Pitfalls and lessons learned Abeer Shaaban
    4. Slide Seminar: Case Demo Instructors/Discussants: Cecily Quinn, Sarah Pinder, Abeer Shaaban
  19. Hall E Oral papers

    Oral Papers Session I

    Medical Oncology & Radiation Oncology

    1. OP-007: Differences in the clinical and molecular phenotype in breast cancer patients with germline pathogenic variants in BRCA1, BRCA2 and non BRCA HRR genes (PALB2, ATM & CHEK2) Aanchal Pandey
    2. OP-008: Inflammation Meets Targeted Therapy: NLR and PLR Predict Axillary Response in HER2-Positive and HER2-Negative Luminal B Breast Cancer Perya Abbasoglu
    3. OP-009: Drivers of the Oncotype DX Recurrence Score: Real-World Clinicopathologic Correlates in ER-Positive/HER2-Negative Early Breast Cancer Damla Acikel
    4. OP-010: Prognostic Value of Relative Ki-67 Change After Primary Systemic Therapy in Luminal HER2-Negative Breast Cancer Elifsu Turkmen
    5. OP-011: Real-World Effectiveness of CDK4/6 Inhibitors Plus Endocrine Therapy in ER-Low (1–10%) HR+/HER2- Metastatic Breast Cancer: A Single-Center Cohort Study Mounir Belcadi Abbassi
    6. OP-012: Imaging characteristics and clinical significance of incidental axillary lymph nodes on radiotherapy planning tomography in breast cancer patients Meltem Kirli Bolukbas
    7. OP-013: Long-term outcomes of Intraoperative radiotherapy as a boost in early breast cancer patients with high-risk features for local recurrence Udom Tangtrakulwongse
    8. OP-014: A retrospective analysis of sequencing of Palliative-RT with CDK4/6i in hormone receptor positive, HER2-negative metastatic breast cancer. (PARDON) Pratik Ganesh Devde
  20. Hall A

    Lunch

  21. Hall A

    Plastic and Reconstructive Surgery Session III

    More About Breast Reconstruction and Lymphedema

    1. The role of the plastic surgeon in breast conserving surgery Moustapha Hamdi
    2. Local perforator flaps in breast-conserving surgery Alexander Petrovsky
    3. Immediate LVA following mastectomy: Technical considerations and outcome analysis for best practice Gemma Pons
    4. Long term results of surgical treatment of breast cancer related lymphedema Sinikka Suominen
    5. Radiation therapy and breast reconstruction Piotr Krivorotko
    6. Risks and merits of autologous breast reconstruction Mehmet Bayramicli
    7. Q&A / Discussion
  22. Hall B Oral papers

    Best Papers Session

    1. OP-001: Clinical Impact of Polygenic Risk Score Integration into CanRisk in Women with Familial Breast Cancer Risk and Negative Germline Testing: A Prospective Multicenter Study (PRoScreen) Cornelia Leo
    2. OP-002: Strategies to reduce high VUS rates in germline next-generation sequencing (NGS) panel testing in Non Caucasian cohorts and developing counselling approaches for VUS: Results from the 6K Indian Breast Cancer Cohort Rajiv Sarin
    3. OP-003: Mammographic assessment of volumetric evolution after breast-conserving therapy (MARVEL) Nimisha Sharma
    4. OP-004: Candidate-proxy diagnostic performance of artificial intelligence candidate lesion scores on automated breast ultrasound Bera Koca
    5. OP-005: Multivariable Prediction Model for Triple-Negative Breast Cancer Using Ultrafast Dynamic Contrast-Enhanced MRI: Development and Internal Validation Filiz Çelebi
    6. OP-006: The impact of BMI on disease-free and overall survival in breast cancer patients: a multicenter retrospective cohort study Climke Mulder
  23. Hall C

    Session VIII

    Current Breast Cancer Treatments: From Science to Clinical Practice

    1. Access to clinical trials: Barriers, equity, and opportunities Marzia Zambon
    2. Radiotherapy innovations for the future Yasemin Atagun
    3. Symptom and toxicity management in modern therapies Elif Şenocak Taşçı
    4. Enhancing patient adherence and safety: The nursing perspective Dilek Yildirim
    5. Q&A / Discussion
  24. Hall E Oral papers

    Oral Papers Session II

    Radiology

    1. OP-015: Opportunistic mammography screening achieves high cancer detection and eatly-stage diagnosis: A 7,116 examination analysis from Karachi, Pakistan Uzma Shamsi
    2. OP-016: Comparison of preoperative breast cancer disease extent on Contrast-Enhanced Mammography (CEM) versus Magnetic Resonance Imaging (MRI) Nadin Jallad
    3. OP-017: Distinguishing Vendor Effects from the Impact of Tomosynthesis Input in Breast AI: A Two-Step Comparative Study Deniz Gülkan
    4. OP-018: Structured radiologist assessment versus a deep-learning composite model for benign-malignant breast lesion classification on DCE-MRI Filiz Çelebi
    5. OP-019: Performance of an AI model for image-based risk assessment compared to a traditional risk model Kaan Celik
    6. OP-020: Percutaneous Cryoablation for Early-Stage Breast Cancer: Initial Experience and Short-Term Outcomes Inci Kizildag Yirgin
  25. Hall D

    Europa Donna Forum – Roundtable Discussion

    From Patient Voice to Community Action: Addressing Unmet Needs in Breast Cancer · Patient Advocacy Representatives: Albania · North Macedonia · Kosovo · Serbia · Bosnia and Herzegovina · Turkiye

    Moderators
    Marzia Zambon
  26. Hall A Satellite symposium

    Satellite Symposium

    Proton Therapy in Türkiye with the Latest-Generation MEVION S250-FIT: First Patient Treatments to Begin in 2027

  27. Hall B Satellite symposium

    Satellite Symposium

    Navigating Adjuvant Treatment Decisions with Oncotype DX®: A Case-Based Approach

    Moderators
    Umut Demirci
  28. Hall A

    Coffee Break

  29. Hall A Workshop

    Workshop

    Radiation Oncology Workshop Clinical Practices for Axilla Management

    1. Omission of sentinel lymph node biopsy (SLNB) in clinical practice Oreste Gentilini
    2. Radiation therapy when SLNB Is omitted Kamuran Ibis
    3. Radiation therapy when axillary lymph node dissection (ALND) is omitted in SLNB+ patients Senem Alanyali
    4. Omission of ALND after neoadjuvant chemotherapy (In cN2, ypNi, ypNmic, ypNmacro patients) Thorsten Kühn
    5. Omission of radiation therapy in patients cN+ who convert to ypN0 after neoadjuvant chemotherapy Gül Alço
    6. Q&A / Discussion
    7. Nuran Beşe · Case discussion, Oreste Gentilini, Thorsten Kühn, Melis Gultekin, Mehmet Eren, Ozge Gumusay, Valeria Romeo, Marjolein Smidt, Neslihan Cabioglu
  30. Hall B

    Medical Oncology Session II

    Updates in Adjuvant Treatment of Early Breast Cancer

    1. Recent developments and controversies in adjuvant CDKi use William J. Gradishar
    2. Optimal management of invasive lobular cancer Erhan Gokmen
    3. Management of ER-low disease Gul Basaran
    4. Q&A / Discussion
    5. Berna Oksuzoglu, Ozlem Er · Case discussion, Mutlu Dogan, Seden Kucucuk, Markus Niemeyer, Sibel Gürdal, Joseph Gligorov · Gizem Guney
  31. Hall C

    Lymphedema in Breast Cancer: Prevention, Early Intervention, and Modern Management

    1. Integrating breast and lymphatic reconstruction after breast cancer Anil Demiroz
    2. Ultrasound in lymphatic surgery: How this changed my practice Giuseppe Visconti
    3. Microsurgical approaches to lymphedema treatment: LVA, VLNT, and hybrid techniques Dicle Yasar Aksoyler
    4. Optimizing clinical outcomes in lymphedema surgery: Role of preoperative and postoperative physiotherapy Faika Nur Erkol
    5. Is lymphedema expected after sentinel lymph node biopsy? Kübra Türker Karayazı
    6. Operating room process to reduce the risk of lymphedema during breast surgery Nuran Aysen Pamir Aksoy
    7. Early diagnosis of lymphedema after mastectomy and nursing management Nermin Ocaktan
    8. Q&A / Discussion
  32. Hall D

    Dutch Innovation Session: Revolution in Breast Reconstruction – From Fat Transplantation to Regenerative Medicine

    1. Total breast reconstruction with autologous fat transfer An Deliaert
    2. What do we know about autologous fat transfer – From myths to evidence Andrzej Piatkowski De Grzymala
    3. Innovative fat grafting: A new way for regenerative medicine Patricia Dankers
    4. Q&A / Discussion
  33. Hall E Oral papers

    Oral Papers Session III

    Surgery

    1. OP-021: Polyurethane versus ADM in irradiated prepectoral breast reconstruction: a meta-analysis Gizem Oner
    2. OP-022: Prepectoral versus Subpectoral Implant-Based Breast Reconstruction Following Mastectomy: A Randomized Controlled Trial in Indian Breast Cancer Patients Gajendra Pandit
    3. OP-023: Large-volume prepectoral direct-to-implant breast reconstruction: a prospective case series Mahmoud A Alhussini
    4. OP-024: Skin-and Nipple-Sparing Mastectomy with Immediate Breast Reconstruction via Prepectoral Prosthesis Placement Approach and Lipofilling of the Skin Cover for Small- and Medium-Sized Breasts: A Retrospective Study Sally Mohamed Hegab
    5. OP-025: Comparison of immediate and delayed autologous breast reconstruction methods: A retrospective cohort study Ilona Selimovna Duadze
    6. OP-026: Three-Dimensional Simulation in Breast Augmentation: A Systematic Review Suat Morkuzu
    7. OP-027: Chest Wall Perforator Flaps Safely Extend Breast Conservation for Large Tumors: A Propensity Score–Matched Comparative Study Bahadir Emre Baki
    8. OP-028: Assessment of breast cosmesis using deep neural networks (ABCD): The future of cosmetic assessment Arushi Ramesh Kawale

Saturday, 10 October 2026

  1. Hall A

    Hellenic Society of Breast Surgery (EXEM) Session

    Decision-Making: Choosing the Optimum Surgical Technique

  2. Hall B

    Early Morning Radiation Oncology Session

    Bring Your Case Discussion

  3. Hall A

    American Society of Breast Surgeons (ASBrS) Session

    Ductal Carcinoma In Situ (DCIS)

    1. Should pleomorphic/florid LCIS be treated like DCIS? Jill Dietz
    2. Single institution implementation of DecisionRT Shawna Willey
    3. What’s new in margin analysis for DCIS? Susan Boolbol
    4. Observation of DCIS: Who’s a candidate? Kristalyn Gallagher
    5. Multidisciplinary panel: Managing large-volume DCIS Case Presenter: Kristalyn Gallagher Susan Boolbol · Youssef Zeidan, William J. Gradishar, Jill Dietz, Shawna Willey
  4. Hall B

    Technology Session

    New Tools for Better Care

    1. Image-guided breast surgery: AI-combined applications Theo Ruers
    2. Minimally invasive endoscopic breast surgery: Would it be a standard of care? Ahmad Matalkah
    3. Patient-derived cancer organoids: Avatars for drug testing Betul Karademir Yilmaz
    4. Liquid biopsy for diagnosis, treatment planning and follow-up Tarkan Yetişyiğit
    5. Q&A / Discussion
  5. Hall C

    Session IX

    Beyond Treatment: Survivorship Care in Breast Cancer

    1. Long-term and late effects of breast cancer treatment Grazyna Suchodolska
    2. Integrating survivorship care plans into practice and implications for patient outcomes Yasemin Uslu
    3. Charting the breast cancer journey: Patient experiences from diagnosis to treatment Başak Oyan Uluç
    4. Returning to life: Work, social roles, and invisible challenges Bengi Kepkep
    5. Q&A / Discussion
  6. Hall D Satellite symposium

    Satellite Symposium – Masterclass: Sanovis – Polytech

    Implant Technologies: From Diversity to Clinical Results

    1. How did B-Lite Microthane changed my surgery approach Moustapha Hamdi
    2. Long term results with DTI prepec technique in reconstructive surgery Giuseppe Visconti
    3. Prepectoral or subpectoral? Decision-making in implant-based breast reconstruction Akin Yucel
    4. How did Microthane surface shaped my reconstructive surgery Sevgi Yazar
    5. Impact of diverse implant technologies to reconstructive breast surgery Buse Capkinoglu
  7. Hall E Oral papers

    Oral Papers Session IV

    Surgery

    1. OP-029: Targeted sentinel node biopsy (TSNB) in patients with limited nodal disease undergoing primary surgery – initial results of the NodeSMART study Ahmed Hamad
    2. OP-030: Axillary reverse mapping (ARM) technique with indocyanine green (ICG) in breast cancer patients with axillary lymph node dissection ALND Simona Ioana Filip
    3. OP-031: A phase I feasibility study of axillary reverse mapping for arm-related quality of life assessment in locally advanced breast cancer patients undergoing axillary surgery after neoadjuvant chemotherapy Garvit Garg
    4. OP-032: Vascularized Lymph Node Transfer versus Lymphaticovenous Anastomosis for Chronic Breast Cancer–Related Lymphedema: A Systematic Review Suat Morkuzu
    5. OP-033: Single – port endoscopic nipple sparing mastectomy using the HandX motorized handheld articulating system: technique and initial outcomes Ioannis Papapanagiotou
    6. OP-034: Beyond Feasibility and Cosmetic Outcomes: A Systematic Review and Meta-analysis on Learning Curve, Operative Efficiency, Cost, and Implementation of Endoscopic Versus Robotic Nipple-Sparing Mastectomy Animesh Jose
  8. Hall B Satellite symposium

    Satellite Symposium

    ORSERDU: A Targeted Approach in ESR1-Mutated Metastatic Breast Cancer

  9. All halls

    Coffee Break

  10. Hall A

    Session: Loco-Regional Treatment in Early Breast Cancer: at Upfront Setting

    1. Is breast-conserving therapy (BCT) better than mastectomy? Amit Agrawal
    2. Is it time to abandon mastectomy in multicentric cancers? Raghavan Vidya
    3. Accelerated breast radiotherapy (RT) in early breast cancer (eBC): Partial (APBI) or whole (AWBI) breast irradiation? Anusheel Munshi
    4. What should be the minimum safe surgical margin after BCT? Revisiting the recent data Fiorita Poulakaki
    5. Breast RT in the era of sentinel lymph node (SLN) biopsy omission Youssef Zeidan
    6. Node-positive luminal cancer: Can we avoid toxic treatments such as axillary dissection (AD) and neoadjuvant chemotherapy? Sophocles Lanitis
    7. Revisiting omission of AD in SLN-positive patients in the CDK4/6i era Christos Markopoulos
    8. Q&A / Discussion
  11. Hall B

    Medical Oncology Session III

    Response-Guided Systemic Treatment Strategies to Optimize Outcomes in Early Breast Cancer

    1. HR+ disease Joseph Gligorov
    2. HER2+ disease Giuseppe Curigliano
    3. Triple-negative breast cancer Aydah Alawadhi
    4. Özlem Sönmez, M. Umit Ugurlu · Case discussion, Giuseppe Curigliano, Maggie Banys-Paluchowski, Fatma Tokat, Ayfer Ay, Yasemin Kemal · Osman Butun
    5. Q&A / Discussion
  12. Hall C Panel

    Panel Dicussion: Palliative care in breast cancer: What would you do? Perspectives from Africa, Europe and the Middle East

    Panel Contributor: Berkay Alikan

    Moderators
    Gülbeyaz Can
  13. Hall D Oral papers

    Oral Papers Session V

    Surgery

    1. OP-035: Oncological outcomes of breast conserving surgery versus mastectomy for multiple ipsilateral breast cancers Hussain A. Abdulla
    2. OP-036: Breast-conserving surgery is associated with improved long-term survival compared with mastectomy after neoadjuvant chemotherapy: an 8.5-year propensity score–matched analysis Adnan Gundogdu
    3. OP-037: Long-term oncologic safety of subcutaneous mastectomy with immediate reconstruction after primary systemic therapy for breast cancer Busra Yesilova
    4. OP-038: The value of pre-operative imaging modalities in reducing re-excision rates in the era of breast conservation surgery: A single center retrospective study Elissavet Symeonidou
    5. OP-039: Tissue-sparing breast-conserving surgery with SAVI SCOUT: comparable oncologic outcomes and reduced specimen volume versus wire-guided localization Eleonora Savia
    6. OP-040: Effect of Quilting Sutures on Postoperative Outcomes Following Mastectomy: A Systematic Review and Meta-Analysis Marwan Emad Abdou
    7. OP-041: Can Drains Be Omitted After Mastectomy? A Pilot Feasibility Study of Drainless Mastectomy with Skin-Flap Quilting Esraa Alzahrani
    8. OP-042: Diagnostic value of the H-Score for prediction of borderline & malignant subtypes in phyllodes tumors Aysegul Ergun
  14. Hall E Workshop

    Sirius-sponsored Workshop: Oncoplastic Breast-Conserving Surgery: New Standard of Care in Turkiye

    Speakers & Tutors: Leena Chagla, Kemal Atahan, Cem Yilmaz, Guldeniz Karadeniz Cakmak, Nur Soylu Boy, Merve Gursoy · (Closed Meeting Only by Invitation)

  15. Hall A

    Lunch

  16. Hall A

    Breast Global Session

    Surgery After Neoadjuvant Systemic Treatment (NST)

    1. To dissect or not to dissect: Axillary management when targeted axillary dissection (TAD) Is not feasible in cN1 converted to yN0 axilla Urvashi Jain
    2. ypN1: Is no surgery an option? Ashutosh Kothari
    3. Ashutosh Kothari, Sophocles Lanitis, Michalis Kontos · Post NST management of breast, axilla, Urvashi Jain, Sanjay Yadav, Anusheel Munshi, Michalis Kontos, Jayanti Thumsi, Norran Hussein, Sana Al Sukhun, Sarah Pinder
  17. Hall B

    Survivorship Session

    Challenging Issues: Building a Multidisciplinary Care Model for Fertility in Young Breast Cancer Patients

    1. Current concepts in fertility preservation Bulent Tiras
    2. Management of young patients with fertility concerns Maha Alsindi
    3. Changing concepts in hormonal replacement and side-effect management Cem Iyibozkurt
    4. Panel Discussion Feyza Ozturk · Matti Aapro, Fulya Soybas, Guzin Unlu Suvari, Bulent Tiras, Cem Iyibozkurt, Mary Jimenez
  18. Hall D Oral papers

    EUBREAST Best Papers Session

    1. OP-043: Breast Sensibility and Quality of Life After Reconstruction: A BREAST-Q–Based Outcome Analysis Laura Raducu
    2. OP-044: Randomised trial of biological versus synthetic mesh in implant-based breast reconstruction: results from the BIOSYM feasibility study (ClinicalTrials.gov: NCT05449691) Ahmed Hamad
    3. OP-045: End of enrollment and initial oncologic outcomes of the NEONOD2 Trial: A prospective Italian multicenter study on axillary de-escalation in ypN1mi breast cancer patients after neoadjuvant chemotherapy Damiano Gentile
    4. OP-046: Initial results of the international multicenter MINDS-DCIS study: does margin width <2 mm influence recurrence after surgery for ductal carcinoma in situ? Damiano Gentile
    5. OP-047: Improved overall survival with breast-conserving surgery and radiotherapy versus mastectomy for stage I–III breast cancer: a National Cancer Database analysis Magdalena Lombardi Plasilova
    6. OP-048: Evaluation of Node marking techniques and targeted axillary dissection in cN1 patients undergoing neoadjuvant chemotherapy – results from 1080 participants in the ATNEC randomised phase III trial (NCT04109079) Abeer Shaaban
  19. Hall A

    Coffee Break

  20. Hall A

    Advanced Disease Session

    Narrators
    Neris Dincer
    1. Role of local ablative treatment in metastatic breast cancer Meena Moran
    2. Case 1 Oligometastatic Disease
    3. Case 2 Isolated Sternal Metastasis
    4. Case 3 Contralateral Axilla Metastasis
  21. Hall B

    EUBREAST Session

    An International Effort to Improve Breast Cancer Surgery Research

    1. Introduction and welcome Thorsten Kühn
    2. EUBREAST: Mission and organization Oreste Gentilini
    3. AXSANA trial (Surgical management of N+ patients at baseline who turn into N- after PST) Thorsten Kühn
    4. EUBREAST-01 trial (Omission of SLNB in TNBC or HER2+ breast cancer after primary systemic therapy) Oreste Gentilini
    5. MELODY trial (What is the best method to localize non palpable breast lesions?) Maggie Banys-Paluchowski
    6. I-PREPARE: Pre-pectoral direct to implant reconstruction: the new standard of care? Oreste Gentilini
    7. EUBREAST-24 SLYMT-AXSANA: Patients with breast cancer and nodal metastasis: Sentinel lymph node biopsy versus targeted axillary dissection after primary systemic treatment. A randomized controlled trial Maria Luisa Gasparri
    8. New ideas turning into trials Nina Ditsch
    9. Closing remarks Oreste Gentilini
  22. Hall C

    Session X

    Vulnerable Populations in Breast Cancer

    1. Socioeconomic barriers in breast cancer care: Access, inequality, and support needs Seda Er
    2. Older patients and multimorbidity: Adapting breast cancer care Berkay Alikan
    3. Young women with breast cancer: Life disruption beyond treatment Yasemin Uslu
    4. Handling difficult questions: Communication skills in nursing Gizem Sahin Bayindir
    5. Breast cancer in pregnancy Selin Ozaltin
    6. Nursing challenges in breast cancer during pregnancy and the postpartum period Merve Tuncer
    7. Q&A / Discussion
    8. Closure & final evaluation
  23. Hall D Oral papers

    Oral Papers Session VI

    Breast Nurse & Breast Pathology & Supportive Care & Others

    1. OP-049: The impact of smoking on disease-free and overall survival in breast cancer patients: a multicenter retrospective cohort study Lotte Van Hout
    2. OP-050: Sexual Function by Surgical Method in Women with Breast Cancer Receiving Adjuvant Tamoxifen: A Comparative Study Selin Ozaltin
    3. OP-051: Identifying High-Impact Patient Cohorts in Breast Cancer Through Large-Scale Survival Modeling Balazs Gyorffy
    4. OP-052: Tumoral Galectin-3 expression predicts survival and metastatic progression in triple-negative breast cancer Said Bugra Taskin
    5. OP-053: Postoperative changes in Prognostic Nutritional Index and predictors of nutritional deterioration in patients undergoing breast cancer surgery Hande Koksal
    6. OP-054: The Effect of Nurse-Led Coaching Program on Self-Care Agency and Quality of Life in Reconstructed Breast Cancer Patients: A Randomized Controlled Trial Nihal Yıldız Emre
    7. OP-055: Prevalence of Neuropathic Pain After Breast Surgery and Its Effect on Patient Comfort Rabia Yıldız Yakar
    8. OP-056: Knowledge and awareness of fertility preservation and associated factors among women undergoing breast cancer treatment Merve Tuncer
  24. Hall A Ceremony

    Closing Ceremony

    Awards&Adjourn

Cookie settings

Cookie policy